Hypertension effective treatment coverage (controlled hypertension) in China
China: Hypertension effective treatment coverage (controlled hypertension) was 15.6% in 2019. ◆ Volatile
Hypertension effective treatment coverage (controlled hypertension) in China, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension effective treatment coverage (controlled hypertension) in China stood at 15.6%. That is the highest value across all 30 years on record.
That represents a change of up 2.0% on the previous year and up 38.1% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in China peaked at 15.6% in 2019 and was at its lowest, 2.4%, in 1990.
That places China 108th out of 193 countries with data for 2019, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Hypertension effective treatment coverage (controlled hypertension) in China, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 2.4% | — |
| 1991 | 2.6% | +8.3% |
| 1992 | 2.8% | +7.7% |
| 1993 | 3.1% | +10.7% |
| 1994 | 3.4% | +9.7% |
| 1995 | 3.7% | +8.8% |
| 1996 | 4.0% | +8.1% |
| 1997 | 4.4% | +10.0% |
| 1998 | 4.8% | +9.1% |
| 1999 | 5.2% | +8.3% |
| 2000 | 5.6% | +7.7% |
| 2001 | 6.1% | +8.9% |
| 2002 | 6.6% | +8.2% |
| 2003 | 7.2% | +9.1% |
| 2004 | 7.8% | +8.3% |
| 2005 | 8.5% | +9.0% |
| 2006 | 9.2% | +8.2% |
| 2007 | 9.9% | +7.6% |
| 2008 | 10.6% | +7.1% |
| 2009 | 11.3% | +6.6% |
| 2010 | 11.9% | +5.3% |
| 2011 | 12.6% | +5.9% |
| 2012 | 13.2% | +4.8% |
| 2013 | 13.6% | +3.0% |
| 2014 | 14.1% | +3.7% |
| 2015 | 14.4% | +2.1% |
| 2016 | 14.7% | +2.1% |
| 2017 | 15.0% | +2.0% |
| 2018 | 15.3% | +2.0% |
| 2019 | 15.6% | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.6% | 2.4% | 5.2% | 10 |
| 2000s | 8.3% | 5.6% | 11.3% | 10 |
| 2010s | 14.0% | 11.9% | 15.6% | 10 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Population ages 75-79, female, annual growth rate 9.12 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0153 units per person (2025)
- Population ages 75-79, male, annual growth rate 7.63 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0122 units per person (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in China?
- Hypertension effective treatment coverage (controlled hypertension) in China was 15.6% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in China?
- The highest recorded value was 15.6% in 2019.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in China?
- The lowest recorded value was 2.4% in 1990.
- How does China rank for hypertension effective treatment coverage (controlled hypertension)?
- China ranks 108th out of 193 countries with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in China?
- Over the last ten years it is up 38.1%. The long-run trend across the full record is volatile.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).